Cereblon in health and disease

Pflugers Arch. 2016 Aug;468(8):1299-309. doi: 10.1007/s00424-016-1854-1. Epub 2016 Jun 24.

Abstract

Cereblon (CRBN) is a substrate receptor of the E3 ubiquitin ligase complex that has been linked to autosomal recessive non-syndromic mental retardation. Several key findings suggest diverse roles of CRBN, including its regulation of the large-conductance calcium- and voltage-activated potassium (BKCa) channels, regulation of thalidomide-binding proteins, and mediation of lenalidomide treatment in multiple myeloma. Recent studies also indicate that CRBN is involved in energy metabolism and negatively regulates AMP-activated protein kinase signaling. Mice with genetic depletion of CRBN are resistant to various stress conditions including a high-fat diet, endoplasmic reticulum stress, ischemia/reperfusion injury, and alcohol-related liver damage. In this review, we discuss the various roles of CRBN in human health and disease and suggest avenues for further research to enhance our basic knowledge and clinical application of CRBN.

Keywords: AMPK; BKCa; Cereblon; E3 ligase complex; Immunomodulatory drugs; Mental retardation.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Animals
  • Carrier Proteins / metabolism
  • Humans
  • Peptide Hydrolases / metabolism*
  • Protein Binding / physiology
  • Signal Transduction / physiology
  • Ubiquitin-Protein Ligases / metabolism*

Substances

  • Carrier Proteins
  • Ubiquitin-Protein Ligases
  • AMP-Activated Protein Kinases
  • Peptide Hydrolases